Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised PatientsMarta Francesca Di Pasquale, Milena Encheva, Giovanni Sotgiu et al.|Clinical Infectious Diseases|2018Cited by 256
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registryGiorgio Walter Canonica, Massimo Triggiani, Giorgio Lorenzo Colombo et al.|World Allergy Organization Journal|2019Cited by 119
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registryRaja Dhar, Nayan Sri Gulecha, Aditya Jindal et al.|European Respiratory Journal|2022Cited by 97
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli et al.|Allergy|2020Cited by 85
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective TherapySusanna Esposito, Nicola Principi, Gayatri Amirthalingam et al.|Frontiers in Immunology|2023Cited by 28